Home Cart Sign in  
Chemical Structure| 870487-10-8 Chemical Structure| 870487-10-8
Chemical Structure| 870487-10-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Linker for Antibody-Drug-Conjugation (ADC). The Val-Cit will specifically be cleaved by catepsin B. As this enzyme is only present in the lysosome the ADC payload will be release only in the cell.

Synonyms: Boc-Val-Cit-PAB-PNP

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Boc-Val-Cit-PAB-PNP

CAS No. :870487-10-8
Formula : C30H40N6O10
M.W : 644.67
SMILES Code : O=C(OCC1=CC=C(NC([C@@H](NC([C@@H](NC(OC(C)(C)C)=O)C(C)C)=O)CCCNC(N)=O)=O)C=C1)OC2=CC=C([N+]([O-])=O)C=C2
Synonyms :
Boc-Val-Cit-PAB-PNP
MDL No. :MFCD22417105
InChI Key :SKWLDDHVHXQPOG-ZEQRLZLVSA-N
Pubchem ID :75412383

Safety of Boc-Val-Cit-PAB-PNP

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of Boc-Val-Cit-PAB-PNP

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 870487-10-8 ]

[ 870487-10-8 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 870487-10-8 ]
  • [ 474645-27-7 ]
  • C63H102N10O14 [ No CAS ]
YieldReaction ConditionsOperation in experiment
59% General procedure: One batch of reaction was carried out as following: a solution of compound 4 (1.2 g, 1.68 mmol) in DMF (10 mL) was added DIEA (1.22 mL, 6.98 mmol,) under nitrogen atmosphere, the solution was stirred at 0 °C for 10 mm, then HOBt (226 mg, 1.68 mmol) and MMAE (1.00 g, 1.40 mmol) were added thereto, the mixture was degassed and purged with N2 for 3 times, which was stirred at 35 °Cfor 16 hr. LC-MS (ES8396-1-P1A1, product: RI = 1.19 mm) showed compound 4 was consumed completely and one main peak with desired mass was detected. The resulting reaction mixture of five batches was combined in 1 L of beaker and 500 mL water was added, then a precipitate was formed and filtered to collect. The precipitate was triturated with EtOAc overnight. Compound 5 (5 g, 59percent yield) was obtained as a white solid.
45% With pyridine; benzotriazol-1-ol; N-ethyl-N,N-diisopropylamine; In tetrahydrofuran; for 48h; Boc-Val-Cit-PAB-OH 26 (100 mg, 0.2 mmol) was suspended in a mixture of anhydrous DMF (1 mL), THF (2 mL) and CH2Cl2 (1 mL), followed by the addition of pyridine (97 muL, 1.2 mmol) and 4-nitrobenzoyl chloride (115 mg, 0.62 mmol). After 2 hours the solvent was removed and purified by silica gel chromatography eluting with CH2Cl2 (100percent), then 5percent MeOH/CH2Cl2 to give 89 mg (69percent) of Boc-Val-Cit-PAB-OpNP 55. Then, MMAE (88.6 mg, 0.123 mmol) was dissolved in a mixture of THF (2.8 mL) and pyridine (0.7 mL) followed by the addition of DIPEA (212 muL), HOBt (5.6 mg, 0.039 mmol) and Boc-Val-Cit-PAB-OpNP 55 (89 mg, 0.138 mmol). After 48 hours the solvent was removed and the reaction mixture was then purified by silica gel chromatography eluting with CH2Cl2 (100percent/o), then 15percent MeOH/CH2Cl2 to give 30 mg (45percent) of Boc-Val-Cit-PAB-MMAE 56. . 1H NMR (400 MHz, CDCl3) delta 7.49 (t, J=7.2 Hz, 2H), 7.29-7.08 (m, 11H), 5.13-4.94 (m, 2H), 4.69-4.4 (m, 5H), 4.2-4.05 (m, 4H), 4.97 (bs, 1H), 3.81 (dd, J=2.5 Hz, 6.56 Hz, 1H), 3.77 (dt, J=9.2 Hz, 1.8 Hz, 1H), 3.63-3.55 (m, 2H), 3.44 (m, 1H), 3.35-3.15 (m, 20H), 3.14-3.04 (m, 2H), 3.5-2.95 (m, 3H), 2.9-2.75 (m, 4H), 2.41-2.34 (m, 3H), 2.45 (s, 1H), 2.21 (s, 1H), 2.16-1.55 (m, 16H), 1.54-1.39 (m, 4H), 1.34 (s, 9H), 1.3 (bs, 2H), 1.11-0.95 (m, 11H), 0.9-0.6 (m, 42H).
40.63% A mixture of Compound 4 (1.10 g, 1.71 mmol, 1.00 eq) and DffiA (2.21 g, 17.06 mmol, 2.98 mL, 10.00 eq) in DMF (10.00 mL) was stirred under nitrogen at 0 °C for 30 mins. MMAE (900.00 mg, 1.25 mmol, 0.73 eq) and HOBt (230.56 mg, 1.71 mmol, 1.00 eq) was added to the mixture and the resulting reaction mixture was stirred under nitrogen at 0 °C for 10 min and at 30 °C for additional 18 hr. LC-MS showed Compound 4 was consumed completely and one main peak with desired MS was detected. The reaction mixture was purified by flash CI 8 gel chromatography (ISCO®; 120 g SepaFlash® CI 8 Flash Column, Eluent of 0-50percent MeCN/H20 85 mL/min). Compound 5 (850.00 mg, 694.71 umol, 40.63percent yield) was obtained as a white solid.
 

Historical Records

Categories